- Home
- EFSC vs HCM Comparison
EFSC vs HCM Comparison
Compare EFSC & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFSC | HCM |
|---|---|---|
| Founded | 1988 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | EFSC | HCM |
|---|---|---|
| Price | $54.08 | $13.67 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $65.67 | $13.75 |
| AVG Volume (30 Days) | ★ 202.6K | 28.4K |
| Earning Date | 01-26-2026 | 08-07-2025 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | ★ 8.68 | N/A |
| EPS | ★ 5.13 | 0.53 |
| Revenue | ★ $646,694,000.00 | $602,197,000.00 |
| Revenue This Year | $20.14 | N/A |
| Revenue Next Year | $5.15 | $15.54 |
| P/E Ratio | $10.54 | ★ $5.07 |
| Revenue Growth | ★ 9.31 | N/A |
| 52 Week Low | $45.22 | $11.51 |
| 52 Week High | $62.60 | $19.50 |
Technical Indicators
Market Signals| Indicator | EFSC | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 49.90 |
| Support Level | $55.24 | $13.13 |
| Resistance Level | $55.66 | $13.89 |
| Average True Range (ATR) | 0.94 | 0.32 |
| MACD | -0.31 | 0.07 |
| Stochastic Oscillator | 18.16 | 84.55 |
Price Performance
Historical ComparisonAbout EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.